Jin X - Search Results

1

Enhancement of death receptor 4-mediated apoptosis and cytotoxicity in renal cell carcinoma cells by anisomycin.

Li Y, Wu X, Jin X, Wang J, Togo Y, Suzuki T, Hashimoto T, Yamada Y, Nakanishi Y, Kanematsu A, Nojima M, Kakehi Y, Yamamoto S. Li Y, et al. Among authors: jin x. Anticancer Drugs. 2017 Feb;28(2):180-186. doi: 10.1097/CAD.0000000000000450. Anticancer Drugs. 2017. PMID: 27879498

2

Low concentrations of doxorubicin sensitizes human solid cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-receptor (R) 2-mediated apoptosis by inducing TRAIL-R2 expression.

Wu XX, Jin XH, Zeng Y, El Hamed AM, Kakehi Y. Wu XX, et al. Cancer Sci. 2007 Dec;98(12):1969-76. doi: 10.1111/j.1349-7006.2007.00632.x. Epub 2007 Oct 8. Cancer Sci. 2007. PMID: 17922852 Free PMC article.

3

Induction of apoptosis in human renal cell carcinoma cells by vitamin E succinate in caspase-independent manner.

Wu XX, Kakehi Y, Jin XH, Inui M, Sugimoto M. Wu XX, et al. Urology. 2009 Jan;73(1):193-9. doi: 10.1016/j.urology.2008.04.055. Epub 2008 Aug 9. Urology. 2009. PMID: 18692875

4

Enhancement of death receptor 4 mediated apoptosis and cytotoxicity in renal cell carcinoma cells by subtoxic concentrations of doxorubicin.

Jin X, Wu XX, Abdel-Muneem Nouh MA, Kakehi Y. Jin X, et al. J Urol. 2007 May;177(5):1894-9. doi: 10.1016/j.juro.2007.01.018. J Urol. 2007. PMID: 17437844

5

Delineation of apoptotic genes for synergistic apoptosis of lexatumumab and anthracyclines in human renal cell carcinoma cells by polymerase chain reaction array.

Jin X, Wu XX, Jin C, Inui M, Sugimoto M, Kakehi Y. Jin X, et al. Among authors: jin c. Anticancer Drugs. 2012 Apr;23(4):445-54. doi: 10.1097/CAD.0b013e32834fd796. Anticancer Drugs. 2012. PMID: 22205156

6

Synergistic induction of apoptosis by mapatumumab and anthracyclines in human bladder cancer cells.

Ahmed SM, Wu X, Jin X, Zhang X, Togo Y, Suzuki T, Li Y, Kanematsu A, Nojima M, Yamamoto S, Sugimoto M, Kakehi Y. Ahmed SM, et al. Among authors: jin x. Oncol Rep. 2015 Feb;33(2):566-72. doi: 10.3892/or.2014.3654. Epub 2014 Dec 5. Oncol Rep. 2015. PMID: 25483927

7

Apigenin inhibits renal cell carcinoma cell proliferation through G2/M phase cell cycle arrest.

Bao Y, Wu X, Jin X, Kanematsu A, Nojima M, Kakehi Y, Yamamoto S. Bao Y, et al. Among authors: jin x. Oncol Rep. 2022 Mar;47(3):60. doi: 10.3892/or.2022.8271. Epub 2022 Jan 28. Oncol Rep. 2022. PMID: 35088891

8

Human agonistic antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 2 induces cytotoxicity and apoptosis in prostate cancer and bladder cancer cells.

Shimada O, Wu X, Jin X, Nouh MA, Fiscella M, Albert V, Matsuda T, Kakehi Y. Shimada O, et al. Among authors: jin x. Urology. 2007 Feb;69(2):395-401. doi: 10.1016/j.urology.2006.12.007. Urology. 2007. PMID: 17320696

9

Enhanced susceptibility of adriamycin-treated human renal cell carcinoma cells to lysis by peripheral blood lymphocytes and tumor infiltrating lymphocytes.

Wu XX, Zeng Y, Jin XH, Kakehi Y. Wu XX, et al. Among authors: jin xh. Oncol Rep. 2007 Aug;18(2):353-9. doi: 10.3892/or.18.2.353. Oncol Rep. 2007. PMID: 17611656

10

Expression of TRAIL, DR4, and DR5 in bladder cancer: correlation with response to adjuvant therapy and implications of prognosis.

Li Y, Jin X, Li J, Jin X, Yu J, Sun X, Chu Y, Xu C, Li X, Wang X, Kakehi Y, Wu X. Li Y, et al. Among authors: jin x. Urology. 2012 Apr;79(4):968.e7-15. doi: 10.1016/j.urology.2011.11.011. Epub 2012 Jan 11. Urology. 2012. PMID: 22244504

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,873 results

Search Page

Filters